bioRxivGenomicsPreprint
Convergent evolution of somatic escape variants in SERPINA1 in the liver in alpha-1 anti-trypsin deficiency
Natalia BrzozowskaiD, Lily WuiD, Vera Khodzhaeva, William James GriffithsiD, Adam DuckworthiD, Hyunchul JungiD, Tim H. H. CoorensiD, Yvette E. Hooks, Joseph E. ChambersiD, Peter J CampbelliD, Stefan John MarciniakiD, Matthew HoareiD
Abstract
Somatic variants accumulate in non-malignant tissues with age1,2. Functional variants leading to clonal advantage of hepatocytes accumulate in the liver from patients with acquired chronic liver disease (CLD)3-5. Whether these somatic variants are common to CLD from differing aetiologies is unknown. We analysed somatic variants in the liver from patients with genetic CLD from alpha-1 anti-trypsin (A1AT) deficiency or haemochromatosis. We show that somatic variants in SERPINA1, the gene encoding A1AT, are strongly selected for in A1AT deficiency, with evidence of convergent evolution. Acquired variants cluster at the 3 end of SERPINA1 leading to C-terminal missense or truncation variants of A1AT. In vitro, C-terminal truncation variants abrogate disease-associated A1AT polymerisation and retention in the endoplasmic reticulum, supporting the C-terminal domain swap mechanism. Therefore, somatic escape variants from a deleterious germline variant are selected for in A1AT deficiency, suggesting adaptive functional somatic variants are disease-specific in CLD and point to disease-associated mechanisms.
- organism: human
- assay: DNA methylation
- research focus: differential expression
- approach: statistical model
- Citations
- 1
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Resolution of the circulating pathogenic phenotype of alpha-1 antitrypsin deficiency following liver transplantation
Nina Heyer‐Chauhan, Riccardo Ronzoni, … David A. Lomas·Bioscience ReportsPeer-reviewed·Oct 29, 2026
- Novel Transgenic Humanized Alpha-1 Antitrypsin Deficiency Mouse Model on Murine SERPINA1 Null Background
Regina A. Oshins, Alek M. Aranyos, … Nazli Khodayari·bioRxiv·Oct 11, 2024
- CHOP-c-JUN complex plays a critical role in liver proteotoxicity induced by mutant Z alpha-1 antitrypsin.
Sergio Attanasio, Gwladys Gernoux, … Nicola Brunetti‐Pierri·bioRxiv·May 4, 2020
- Liver biopsy confirms precise and efficient correction of SERPINA1 after in vivo Base Editing in a Patient with Alpha-1 Antitrypsin Deficiency
Simon Alexander Krooss, Taihua Yang, … Michael Ott·medRxiv·Jun 9, 2026
- Both terminal misfolding and polymerisation contribute to disease-relevant phenotypic changes in cell models of alpha-1-antitrypsin deficiency-associated liver disease
Panayiota Stylianou, Kish R. Adoni, … Bibek Gooptu·bioRxiv·Sep 30, 2025
- SAHA increases chaperone expression and reduces Z-alpha-1-antitrypsin polymers in a patient specific iPSC-based liver model for alpha-1-antitrypsin deficiency
Nina Graffmann, Rabea Hokamp, … James Adjaye·Stem Cell Research & TherapyPeer-reviewed·Oct 27, 2026